USPTO Patents Application 09621565

i # - i 1

Applicants
Serial No.
Filed
For

Docket No. JBP0510US

Miri Seiberg et al.
09/621,565
July 21, 2000

Confirmation No.: 4999
Art Unit: 1618

Examiner: Blessing M. Fubara

REDUCING HAIR GROWTH; HAIR FOLLICLE AND HAIR SHAFT
SIZE AND HAIR PIGMENTATION

■ -

I hereby certify that this correspondence is being deposited with the
United States Postal Service as first class mail in ah envelope addressed
to: Commissioner For Patents, P.O. Box 1450, Alexandria, VA 22313*1450 on

November 1 4, 2006;;

(Date of Deposit)

Andrea L. Colby. Reg. No. 30,194

(Name of applicant, assignee, or Registered Representative)

/Andrea L. Colby/

(Signature)

November 14, 2006

(Date of Signature)

Commissioner for Patents
P.O. Box 1450
Alexandria, VA 2231 3-1 450

Dear Sir:

Pursuant to 37 C.F.R. §1.56 and in accordance with 37 C.F.R. §§1.97-1 .98,
information relating to the above-identified application is hereby disclosed. Inclusion of
information in this statement is not to be construed as an admission that this
information is material as that term is defined in 37 C.F.R. § 1.56(b).

Applicant(s) reserve(s) the right to establish the patentability of the claimed
invention over any of the information provided herewith, and/or to prove that this
information may not be prior art, and/or to prove that this information may not be
enabling for the teachings purportedly offered.

U/17/S006 ZJUHBR1 00000047 100750 «WK»
01 FC-.1806 180.00 0ft

This statement should not be construed as a representation that a search has
been made, or that information more material to the examination of the present patent
application does not exist.

□ In accordance with § 1.97(b), since this Information Disclosure Statement
is being filed either within three months of the filing date of the above-identified
national application (other than a continued prosecution application under §1. 53(d)),
within three months of the date of entry into the national stage of the above identified
application as set forth in §1.491 , or before the mailing date of a first Office Action on
the merits of the above-identified application, or before the mailing date of a first Office
Action after the filing of a request for continued examination under §1 .114, no
additional fee is required.

[3 In accordance with § 1 .97(c), this Information Disclosure Statement is
being filed after the period set forth in § 1.97(b) above but before the mailing date of
either a Final Action under §1.113 or a Notice of Allowance under §1.311, or an action
that otherwise closes prosecution and that it is accompanied by one of: •
□ Statement in Accordance with § 1 .97(e) (attached); or
^ Please charge Deposit Account No. 1 0-0750/JBP51 0/ALC the fee
of $180.00 as set forth in §1.17(p).

□ In accordance with § 1.97(d), this Information Disclosure Statement is
being filed after the mailing date of either a Final Action under §1.113 or a Notice of
Allowance under §1.31 1 but before the payment of the Issue Fee. Applicant(s)
hereby petition(s) for consideration of this Information Disclosure Statement. Included
are: Statement in Accordance with § 1.97(e) as set forth below and the fee of $1 80.00
as set forth in §1.1 7(p).

Copies of only foreign patent documents and non-patent literature are
enclosed in accordance with 37 CFR 1 .98 (a)(2).

□ There are no listed references which are not in the English language.

- 2 -

£| The relevance of those listed references which are not in the English
language is as follows:

English language abstracts are provided for the foreign patent documents listed

on the form SB/08/A.

□ Attached are copies of search report(s) from corresponding patent
application(s), which are listed on the attached Submission Under MPEP 609 D.

□ Attached are the following non-published pending patent applications
which may be deemed relevant, which are listed on the attached Submission Under
MPEP 609 D.

Please charge any deficiency or credit any overpayment to Deposit Account
No. 10-0750/JBP510/ALC. This form is submitted in triplicate.

Respectfully submitted,

Johnson & Johnson

One Johnson & Johnson Plaza

New Brunswick, NJ 08933-7003

(732) 524-2792

DATED: November 14, 2006

/Andrea L. Colby/
Andreat. Gdlby
Reg?Nd*30,194"
Attorney. foRApplicants

2006

PTO/SB/08A (08-00)
Approved for use through 10/31/2002. OMB 0651-0031
U.a Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE

'Substitute for form 1449A/PTO

Confirmation Number

4999

INFORMATION DISCLOSURE

Aoolication Number

09/621,565

FilinaDate

07/21/2000

STATEMENT BY APPLICANT

First Named Inventor

Miri Seiberq

Group Art Unit

1618

(use as many sheets as necessary)

Examiner Name

Blessing M. Fubara

Sheet 1 of 1

Attorney Docket Number

JBP0510US

U.S. PATENT DOCUMENTS

Exam
Initials

Cite
No. 1

U.S. Patent Document

Number

Kind Code 2
(if known)

Name of Patentee or Applicant
of Cited Document

Date of Publication
of Cited Document

mm-dd-yyyy

Pages, Columns, Lines,
where relevant passages or
relevant figures appear

5,006,337

5,444,092

Motjtschke et al.

04-09-1991

Collins

08-22-1995

2004/0063593

A1

Wu et al.

04-01-2004

FOREIGN PATENT DOCUMENTS

Exam
Initials

Cite
No.'

Foreign Patent Document

Name of Patentee or
Applicant of Cited Document

Date of
Publication of
Cited Document

mm-dd^yyyy

Pages, Columns,
Lines, where relevant
passages or relevant
figures appear

T 8

Office 3 Number 4 KindCode 6

CN

1081899

A

Wang

02-16-1994

English Abst.

CN

1146876

A

Li

04-09-1997

English Abst.

CN

1166960

A

Jin

12-1 0-1 997

English Abst.

DE

19818849

A

Med-Beauty AG

10-29-1998

English Abst.

DE

4432947

A

New Standard GmbH

03-21-1996

English Abst.

DE

19634206

A

Reinke Ludwig Dr.

03-05-1998

English Abst.

EP

0 581 624

A1

Expanchimie SARL

02-02-1994

English Abst.

EP

0 581 624

B1

Expanchimie SARL

02-02-1994

English Claims

EP

0 582 239

A1

Rhone-Poulenc Rorer

02-09-1994

English Abst.

EP

0 582 239

B1

Rhone-Poulenc Rorer

02-09-1994

English Claims

EP

1 210 946

A

Neutrogena Corp.

06-05-2002

JP'

04283518

A

Kikkoman Corp.

10-08-1992

English Abst.

JP

410226642

A

Kokkoman Corp.

08-25-1998

English Abst.

JP

60061513

A

Sansei Seiyaku KK

04-09-1985

English Abst.

WO

99/00110

A1

Andre et al.

01-07-1999

English Abst.

WO

99/39682

A2

Fernandez-Kleinlein et ai.

08-12-1999

1 Examiner

Date

I Signature

Considered

•EXAMINER: initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not En conformance and not
considered, include copy of the form with next communication to applicant.

i Unique citation designation number. 2 See attached Kinds of U.S. Patent Documents. 3 Enter Office that issued the document, by the two-letter
code (WIPO Standard ST.3), 4 For Japanese patent documents, the indication of the year of ttie reign of the Emperor must precede the serial
number of the patent document. 5 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST. 16 if
possible, e Applicant is to place a check mark here if English language Translation is attached.

Burden Hour Statement: this form is estimated to take 2.0 hours to complete. Time will vary depending upon the needs of the individual case. Any comments on the
amount of time you are required to complete this form should be sent to the Chief information Officer, U. S. Patent and Trademark Office, Washington, DC 20231 .
DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS, SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450